Paxmedica receives emergency request for iv suramin from african health ministry for use in treating fatal sleeping sickness

Tarrytown, new york, april 16, 2024 (globe newswire) -- via ibn --  paxmedica , inc. (nasdaq:  pxmd ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the ministry of health (moh) of malawi, asking for emergency access to iv suramin to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used routinely to save lives in that region of africa.
PXMD Ratings Summary
PXMD Quant Ranking